The Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2019

Type Statutory-Instrument
Publication 2019-01-10
Last updated 2020-12-31
State In force
Department King's Printer of Acts of Parliament
PDF Download
articles Not indexed
Reform history JSON API

Made: 10th January 2019

Coming into force in accordance with regulation 1

The Secretary of State makes these Regulations in exercise of the powers conferred by section 8(1) of, and paragraph 1 of Schedule 4 and paragraph 21 of Schedule 7 to, the European Union (Withdrawal) Act 2018 .

In accordance with paragraphs 1(1) and 12(1) of Schedule 7 to that Act, a draft of these Regulations has been laid before and approved by a resolution of each House of Parliament.

In accordance with paragraph 3(1) of Schedule 4 to that Act, the Treasury has consented to the making of regulation 6(33).

PART 1 — Introduction

Citation and commencement

1

These Regulations may be cited as the Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2019 and come into force on exit day.

PART 2 — Amendment of primary legislation

Amendment of the Tobacco Advertising and Promotion Act 2002

2

PART 3 — Amendment of subordinate legislation

Amendment of the Tobacco Advertising and Promotion (Brandsharing) Regulations 2004

3

Amendment of the Standardised Packaging of Tobacco Products Regulations 2015

4

cross-border distance sale”, in relation to a tobacco product, means a distance sale to a consumer where, at the time the consumer orders the product from a retailer, the consumer is located in the United Kingdom and the retailer is established in another country;

Amendment of the Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015

5

6

(1A) (1) Subject to the following paragraphs, these Regulations extend to England and Wales, Scotland and Northern Ireland. (2) The following provisions do not extend to Northern Ireland— (a) regulation 5A; (b) regulation 7(5); (c) regulation 8(10); (d) regulation 9(12); (e) regulation 10(5); (f) regulation 13(3); (g) regulation 14(5) and (6); (h) regulation 15(3); (i) regulation 16(4); (j) regulation 16A; (k) regulation 20A(6) and (7); (l) regulation 36(11); (m) regulation 37(10); (n) Part 9A; (o) regulations 54ZA and 54ZB. (3) The following provisions extend only to Northern Ireland— (a) regulation 41(3) to (5); (b) regulation 44; (d) regulation 47. (4) An amendment made by these Regulations has the same extent as the provision to which it relates

  • “GB related product” means a related product which is produced for supply, or is supplied, for consumption in Great Britain or through the GB travel retail sector;
  • “GB tobacco product” means a tobacco product which is produced for supply, or is supplied, for consumption in Great Britain or through the GB travel retail sector;
  • “the GB travel retail sector” means retail outlets in Great Britain at which tobacco products or related products may be purchased only by people travelling on journeys to destinations outside Great Britain;
  • “NI related product” means a related product which is produced for supply, or is supplied, for consumption in Northern Ireland or through the NI travel retail sector;
  • “NI tobacco product” means a tobacco product which is produced for supply, or is supplied, for consumption in Northern Ireland or through the NI travel retail sector;
  • “the NI travel retail sector” means retail outlets in Northern Ireland at which tobacco products or related products may be purchased only by people travelling on journeys to destinations outside Northern Ireland;
  • “retailer” means a person who sells, or offers or agrees to sell, a tobacco product or related product to a consumer;
  • “travel retail sector” means—the GB travel retail sector, orthe NI travel retail sector.

(3) In the case of a cross-border distance sale of a product, the product is to be treated for the purposes of these Regulations— (a) where the consumer is located in Great Britain, as supplied, and presented for retail sale in Great Britain; (b) where the consumer is located in Northern Ireland, as supplied, and presented for retail sale in Northern Ireland.

(4) In these Regulations, “cross-border distance sale”— (a) in relation to Great Britain, means a distance sale to a consumer (“C”) where, at the time C orders a product from a retailer, C is located in Great Britain and the retailer is established outside of Great Britain; (b) in relation to Northern Ireland, means a distance sale to a consumer (“C”) where, at the time C orders a product from a retailer— (i) C is located in Northern Ireland or a member State, and (ii) the retailer— (aa) if C is located in Northern Ireland, is established in a member State or another country outside of Northern Ireland; (bb) if C is located in a member State, is established in Northern Ireland, in a different member State or in a country other than Northern Ireland or a member State. (5) For the purposes of paragraph (4)(b) a retailer is deemed to be established in a member State— (a) in the case of a retailer who is a natural person, if that person’s place of business is in that member State, and (b) in any other case, if the retailer has its statutory seat, central administration or place of business, including a branch, agency or any other establishment, in that member State.

(3) A combined health warning must consist of the relevant smoking cessation information and— (a) for a unit pack or container pack of a tobacco product for smoking which is a GB tobacco product, one of the text warnings with the corresponding colour photograph, as listed in the picture library in Schedule A1, or (b) for a unit pack or container pack of a tobacco product for smoking which is an NI tobacco product, one of the text warnings listed in Annex 1 to the Tobacco Products Directive together with a corresponding colour photograph, as specified in the picture library in Annex 2 to that Directive. (3A) For the purposes of paragraph (3), the relevant smoking cessation information is “Get help to stop smoking at www.nhs.uk/quit”.

(5A) Regulations may— (a) amend the text warnings or photographs listed in the picture library in Schedule A1, taking into account scientific and market developments; (b) modify for the purposes of these Regulations as they apply in relation to GB tobacco products the layout, design and proportions specified in the Combined Health Warnings Decision referred to in regulation 5, taking into account different packet shapes.

(A1) A producer of a tobacco product for smoking which is a GB tobacco product (other than an importer) must select the photograph used for the purposes of regulation 5(3)(a) so that each of the 13 photographs appears on between 1/24 to 1/12 of the total number of packs under each brand name produced by that producer within that production year.

(2) An importer of a tobacco product for smoking must use the importer’s best endeavours to ensure— (a) where the product is a GB tobacco product, that the obligation in paragraph (A1) is complied with; (b) where the product is an NI tobacco product, that the obligations in paragraph (1) are complied with.

(4) In this regulation “production year” means a period of 12 months beginning with 20th May and ending with 19th May.

(5) Regulations may amend the wording of the information message in paragraph (2)(b) to be carried by a unit pack or a container pack of a tobacco product for smoking which is a GB tobacco product, taking into account scientific and market developments.

(10) Regulations may amend paragraphs (5) to (8) as regards the precise position of the general warning and the information message on hand rolling tobacco marketed in pouches which is a GB tobacco product, taking into account the different shapes of pouches.

(12) Regulations may amend this regulation as it applies in relation to the production or supply of GB tobacco products, by omitting from paragraph (1) reference to one or more of the products listed in that paragraph if there is a substantial change of circumstances for the product concerned.

(5) Regulations may amend the wording of the health warning in paragraph (2) to be carried by a unit pack or container pack of a smokeless tobacco product which is a GB tobacco product, taking into account scientific developments.

(2) For the purposes of this regulation and regulation 14 as they apply in Great Britain, a person (“P”) manufactures a product for export if, in the course of a business, other than with a view to the product being supplied for consumption in Great Britain or through the GB travel retail sector, P— (a) manufactures the product, or (b) puts a name, trade mark, or other distinguishing mark on the product by which P is held out to be its manufacturer or its originator. Such a product is referred to in this regulation and regulation 14 as a “product for GB export”. (3) For the purposes of this regulation and regulation 14 as they apply in Northern Ireland, a person (“P”) manufactures a product for export if, in the course of a business, other than with a view to the product being supplied for consumption in Northern Ireland or through the NI travel retail sector, P— (a) manufactures the product, or (b) puts a name, trade mark, or other distinguishing mark on the product by which P is held out to be its manufacturer or its originator. (4) Regulations may decrease the maximum emission levels specified in paragraph (1) in relation to— (a) cigarettes which are GB tobacco products, or (b) cigarettes which are products for GB export, where this is necessary, based on internationally agreed standards.

(5) Regulations may modify the methods of measurement of tar, nicotine and carbon monoxide emissions from cigarettes which are GB tobacco products or products for GB export, where this is necessary, based on scientific and technical developments or internationally agreed standards. (6) Any regulations made under paragraph (5) must integrate standards agreed by the parties to the WHO Framework Convention on Tobacco Control or by the World Health Organization for measurement methods.

(3) Regulations may— (a) specify whether a GB tobacco product has a characterising flavour; (b) set , in relation to GB tobacco products, maximum content levels for additives or a combination of additives that result in a characterising flavour.

(4) Regulations may , in relation to GB tobacco products— (a) specify whether a tobacco product contains additives in quantities that increase the toxic or addictive effect, or the CMR properties of that tobacco product at the stage of consumption to a significant or measureable degree; (b) where an additive or a certain quantity thereof has been shown to increase the toxic or addictive effect of a tobacco product, set maximum content levels for that additive.

(16A) (1) Regulations may establish procedures for determining whether a GB tobacco product— (a) has a characterising flavour; or (b) contains additives in quantities that increase the toxic or addictive effect, or the CMR properties, of that tobacco product at the stage of consumption to a significant or measureable degree. (2) Regulations made under paragraph (1) may— (a) provide for any determination to be made by— (i) the Secretary of State; or (ii) a person authorised by the Secretary of State for that purpose; (b) establish, and provide for the operating procedures of, an independent advisory panel; (c) be varied from time to time, including to take account of scientific and market developments in relation to tobacco products; (d) make different provision for different cases or descriptions of case, different circumstances, different purposes or different areas; (e) be revoked. (3) Before making regulations under this regulation the Secretary of State must consult such persons (or representatives of such persons) as appear to the Secretary of State to be likely to be substantially affected by them.

(6) Regulations may amend the list of additives in Schedule 2 as it applies in Great Britain, which list must contain additives— (a) for which initial indications, research, or regulation in jurisdictions outside Great Britain exist suggesting that they have one of the properties set out in regulation 20B(1)(a) to (d); and (b) which are amongst the most commonly used additives by weight or number according to the reporting of ingredients pursuant to regulation 18. (7) For the purposes of this regulation as it applies in Great Britain, the Annex to Commission Recommendation 2003/361/EC concerning the definition of micro, small and medium-sized enterprises is to be read as if— (a) in Article 2— (i) in paragraph 1, for “EUR 50 million, and/or an annual balance sheet total not exceeding EUR 43 million” there were substituted “£44,000,000, and/or an annual balance sheet not exceeding £38,000,000”; (ii) in paragraph 2, for “EUR 10 million” there were substituted “£8,800,000”; (iii) in paragraph 3, for “EUR 2 million” there were substituted “£1,750,000”; (b) in Article 3— (i) in paragraph (2)(a), for “EUR 1 250 000” there were substituted “£1,100,000”; (ii) in paragraph (2)(d), for “EUR 10 million” there were substituted “£8,800,000”; (iii) in paragraph 5, for “by national or Community rules” there were substituted “under the law of Great Britain (or any part of it)”; (c) in Article 5, in paragraph (b), for “national law” there were substituted “the law of Great Britain (or any part of it)”. (8) In this regulation “appropriate authority”— (a) where the product is a GB tobacco product, means the Secretary of State; (b) where the product is an NI tobacco product, means— (i) the Secretary of State, or (ii) the European Commission.

(7) In this regulation “the relevant part of the United Kingdom”— (a) in relation to a tobacco product which is a GB tobacco product, means Great Britain; (b) in relation to a tobacco product which is an NI tobacco product, means Northern Ireland.

(1A) Information which relates to a GB tobacco product must be submitted— (a) in electronic form, and (b) having regard to such technical requirements and procedures as may be specified in guidance issued by the Secretary of State.

(b) provide the European Commission and the competent authorities of the member States with access to information submitted about any NI tobacco product in accordance with regulation 18, 20A or 21, ensuring that trade secrets and other confidential information are treated in a confidential manner;

(a) the name and contact details of— (i) where the product is, or is to be, supplied for consumption in Great Britain or through the GB travel retail sector— (aa) the person who manufactures the product, (bb) the importer of the product (if applicable), and (cc) if neither is based in Great Britain, a responsible person in Great Britain; (ii) where the product is, or is to be, supplied for consumption in Northern Ireland or the NI travel retail sector— (aa) the person who manufactures the product, (bb) the importer of the product (if applicable), and (cc) if neither is based in Northern Ireland or a member State, a responsible person in Northern Ireland or a member State;

(6) In this regulation “the relevant part of the United Kingdom”— (a) in relation to an electronic cigarette which is a GB related product, means Great Britain; (b) in relation to an electronic cigarette which is an NI related product, means Northern Ireland.

(1A) Information which relates to a GB related product must be submitted— (a) in electronic form, and (b) having regard to such technical requirements and procedures as may be specified in guidance issued by the Secretary of State.

(11) Regulations may amend the technical standards in paragraph (10) for the refill mechanism required by paragraph (8) as they apply in relation to GB related products.

(g) where the electronic cigarette or refill container is an NI related product and the producer is not based in Northern Ireland or in a member State, a contact person in Northern Ireland or within a member State.

(10) Regulations may amend the wording of the health warning in paragraph (4) as it applies to unit packets and container packs of GB related products taking into account scientific developments, provided that any such amended warning is factual.

  • “the Union market” means the market of—one or more member States,Northern Ireland, orNorthern Ireland and one or more member States;
  • “third country” means a country other than—Northern Ireland, ora member State.

(4) In this regulation “the relevant market”— (a) in relation to Great Britain, means the market in Great Britain; (b) in relation to Northern Ireland, means the Union Market.

— (i) where the recipient of the service is in Great Britain, for the market in Great Britain; (ii) where the recipient of the service is in Northern Ireland, for the Union market.

(a) a cross-border event or activity;

(1A) In this regulation “cross-border event or activity” means an event or activity which takes place in or has an effect in— (a) Northern Ireland and one or more member States, or (b) two or more member States.

(53A) (1) Regulations may make provision for the charging of fees in connection with the exercise of functions relating to the determination of characterising flavour, toxicity, addictiveness or CMR properties of tobacco products for the purposes of these Regulations as they apply in Great Britain and in relation to GB tobacco products. (2) Regulations made under paragraph (1) may make such provision in relation to fees as may be made by the appropriate authority under paragraph 1(3)(a) or (b) of Schedule 4 to the European Union (Withdrawal) Act 2018 in relation to those functions.

(54ZA) (1) Any power to make regulations under these Regulations— (a) is exercisable by the Secretary of State (and in the case of regulations made under regulation 53A, with the consent of the Treasury) by statutory instrument; and (b) includes power to make— (i) different provision for different cases or descriptions of case, different circumstances, different purposes or different areas; (ii) consequential, supplementary, incidental, transitional or transitory provision or savings. (2) A statutory instrument containing regulations made under— (a) regulation 53A may not be made unless a draft of the instrument has been laid before, and approved by a resolution of, each House of Parliament; (b) any other provision of these Regulations is subject to annulment in pursuance of a resolution of either House of Parliament. (54ZB) Where the Secretary of State proposes to make regulations under these Regulations which will apply in Wales or Scotland, the Secretary of State must consult— (a) the Welsh Ministers, in respect of any proposed application in Wales; and (b) the Scottish Ministers, in respect of any proposed application in Scotland; ... (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . before making such regulations.

SCHEDULE A1

¹ Corresponding photographs in numbers 1 to 10 and 13 © Commonwealth of Australia. Corresponding photographs in numbers 11 and 12 © Professor Laurence J Walsh, The University of Queensland. ¹ Corresponding photographs in numbers 1 to 10 and 13 © Commonwealth of Australia. Corresponding photographs in numbers 11 and 12 © Professor Laurence J Walsh, The University of Queensland. ¹ Corresponding photographs in numbers 1 to 10 and 13 © Commonwealth of Australia. Corresponding photographs in numbers 11 and 12 © Professor Laurence J Walsh, The University of Queensland.
Number Text Warning Corresponding Photograph¹
1 Smoking clogs your arteries [image omitted]
2 Don't let children breathe your smoke [image omitted]
3 Smoking causes blindness [image omitted]
4 Smoking causes lung cancer [image omitted]
5 Smoking doubles your risk of stroke [image omitted]
6 Tobacco smoke is toxic [image omitted]
7 Smoking harms unborn babies [image omitted]
8 Smoking causes peripheral vascular disease [image omitted]
9 Smoking causes emphysema [image omitted]
10 Quitting will improve your health [image omitted]
11 Smoking damages your gums and teeth [image omitted]
12 Smoking damages your gums and teeth [image omitted]
13 Smoking causes throat cancer [image omitted]

PART 4 — Amendment and revocation of retained direct EU legislation

Amendment of Commission Implementing Decision 2015/1842

7

Revocation of Commission Implementing Regulation and Decisions

8

The following Regulation and Decisions are revoked—

PART 5 — Transitional arrangements

Transitional arrangements: supply of existing products

9

Signed

Signed by authority of the Secretary of State for Health and Social Care.

Steve Brine — Parliamentary Under-Secretary of State, — 2019-01-09

We consent

Jeremy Quin — Rebecca Harris — Two of the Lords Commissioners of Her Majesty's Treasury — 2019-01-10

Explanatory note

(This note is not part of the Regulations)

Footnotes

[^f00001]: 2018 c. 16.

[^f00002]: 2002 c. 36.

[^f00003]: Section 2(4) was substituted by S.I. 2006/2369.

[^f00004]: Section 3A was inserted by S.I. 2006/2369.

[^f00005]: Section 4(1) was amended by S.I. 2006/2369.

[^f00006]: Section 5 was amended by S.I. 2006/2369.

[^f00007]: Section 7D was inserted by section 21 of the Health Act 2009 (c.21).

[^f00008]: Subsection (1A) was inserted by paragraph 4(3) of Schedule 4 to the Health Act 2009.

[^f00009]: Subsection (1A) was inserted by paragraph 5(2) of Schedule 4 to the Health Act 2009.

[^f00010]: Subsection (5) was substituted by paragraph 6(3) of Schedule 4 to the Health Act 2009.

[^f00011]: The definition of “EEA State” was inserted by S.I. 2006/2369.

[^f00012]: S.I. 2004/1824.

[^f00013]: S.I. 2015/829.

[^f00014]: S.I. 2015/895.

[^f00015]: S.I. 2016/507.

[^f00016]: Treaty Series No. 13 (2005); Cm 6514.

[^f00017]: Regulation 20A was inserted by S.I. 2016/1127.

[^f00018]: OJ L 124, 20.5.2003, p. 36.

[^f00019]: Regulation 25 was amended by S.I. 2016/1127.

[^f00020]: Regulation 26 was amended by S.I. 2016/1127.

Transitional provision

Editorial notes

[^c23503651]: 2018 c. 16.

[^c23503661]: 2002 c. 36.

[^c23503671]: Section 2(4) was substituted by S.I. 2006/2369.

[^c23503681]: Section 3A was inserted by S.I. 2006/2369.

[^c23503691]: Section 4(1) was amended by S.I. 2006/2369.

[^c23503701]: Section 5 was amended by S.I. 2006/2369.

[^c23503711]: Section 7D was inserted by section 21 of the Health Act 2009 (c.21).

[^c23503721]: Subsection (1A) was inserted by paragraph 4(3) of Schedule 4 to the Health Act 2009.

[^c23503731]: Subsection (1A) was inserted by paragraph 5(2) of Schedule 4 to the Health Act 2009.

[^c23503741]: Subsection (5) was substituted by paragraph 6(3) of Schedule 4 to the Health Act 2009.

[^c23503751]: The definition of “EEA State” was inserted by S.I. 2006/2369.

[^c23503761]: S.I. 2004/1824.

[^c23503771]: S.I. 2015/829.

[^c23503781]: S.I. 2015/895.

[^c23503791]: S.I. 2016/507.

[^c23503801]: Treaty Series No. 13 (2005); Cm 6514.

[^key-24a56d239bdbb196a73825c24f77e24e]: Reg. 1 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-2d9e906f08c89fa059189dea81fa890f]: Reg. 2 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-af047fa75e91262e82b53eccafdb6da5]: Reg. 3 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-d7db1929721b5d341df3c46043661d4a]: Reg. 4 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-b0f64e750c5c3d5d556979a87bfdc200]: Reg. 5 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-860cc47bb9c6e666ea31e67ae3525f75]: Reg. 6 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-f48c4040effc80f0e3db47ac7140f4de]: Reg. 9 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-e4713573340ff1d83f4288b33044e51a]: Reg. 7 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-1e8ded6dc85a763e72cf17ee29e421e5]: Reg. 8 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

[^key-d5a26f821d2a843e0abf985d08482f21]: Reg. 6(1A) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(3)

[^key-af6bb018f60f1d5f55f065e4cff920bf]: Reg. 6(15A) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(18)

[^key-1f5051067a6a37186aff2ad044d8410b]: Reg. 6(16A) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(20)

[^key-bd2a1aab2683551b543dfaaeb5080030]: Reg. 6(19A) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(24)

[^key-66808bcac75e44ac843dabc1415b30c1]: Reg. 6(2) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(4)

[^key-703c437f8f9eebaa7e61ecd7390c9d00]: Reg. 6(3) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(5)

[^key-3ae20f539509a5d3f3faad35011224f4]: Reg. 6(4) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(6)

[^key-7cf1437a0f0680d4c25175dda5762934]: Words in reg. 6(5) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(7)(a)

[^key-010f609d51c0c8c977c54a32f207653d]: Words in reg. 6(5) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(7)(b)

[^key-884d294aa18bf77e1fc3890cee68749a]: Reg. 6(6) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(8)

[^key-01d6d3441d335fbbe84b0b8da7b11914]: Reg. 6(7) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(9)

[^key-2070390137aa4e9bd0e86ffac4c830cc]: Words in reg. 6(8) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(10)

[^key-709f53f4426e98485df06986aeef99bb]: Reg. 6(9) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(11)

[^key-974e58a4cdeff31d36aec19f1fe9f13f]: Words in reg. 6(10) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(12)

[^key-6e51204f5db690e92635c4da358292e1]: Reg. 6(11) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(13)

[^key-4a7669cd7d6622f2dedf8e03c5148c31]: Words in reg. 6(12) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(14)

[^key-64f8f3c2a87254f8719fa2918020b258]: Words in reg. 6(13) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(15)(a)

[^key-7838ce1a0f2bbd1468250ba40fee1404]: Words in reg. 6(13) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(15)(b)

[^key-e73ff7c23c7047600651c76c225f80cd]: Words in reg. 6(14) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(16)

[^key-baa643ca25c4bdd4cc01525b63565d7b]: Words in reg. 6(15) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(17)(a)

[^key-81dd30e19fd00d1bbeaec0e9f775ac47]: Words in reg. 6(15) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(17)(b)

[^key-0f7c6a21c8774ed3a79c190cd934ade2]: Reg. 6(16) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(19)

[^key-6e02ea398666a08d710b1c1673226cef]: Reg. 6(17) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(21)

[^key-cfa05159cb6eb48ab607642abb5608c5]: Reg. 6(18) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(22)

[^key-4d373465fe5cae55c1ae06db063d81b9]: Reg. 6(19) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(23)

[^key-9b0b09327e06c636c37958714daf09fc]: Reg. 6(20) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(25)

[^key-d1438180f8ad6edcab860716818df8f2]: Reg. 6(21) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(26)

[^key-673c7baae2e50ae7abd2e98f2587f8ee]: Words in reg. 6(22) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(27)

[^key-cb37e85c0a677c2ffe60ada6c4be9943]: Reg. 6(23)(a) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(28)(a)

[^key-ee7c442b55e365f512af6c015334eccc]: Words in reg. 6(23)(b) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(28)(b)

[^key-575a13860c58d165bd9d9cdeaae13cad]: Reg. 6(24) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(29)

[^key-1eef479e6a30882937574ea3ffe318ca]: Reg. 6(25) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(30)

[^key-05c6e06ac80e6554874cc5f548ff7f23]: Reg. 6(26) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(31)

[^key-c35a25e2424a05dd5c289fe567464afd]: Reg. 6(27) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(32)

[^key-54564dbf0ebb3c5efbbb7a70990be3ac]: Reg. 6(28) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(33)

[^key-21ce375d1c22219ebab095ec61ee45ef]: Reg. 6(29) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(34)

[^key-7af5120ab949394ebcf30db4f4f2426e]: Reg. 6(30) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(35)

[^key-4430f8643a0031451c46d0f6a66414b1]: Reg. 6(31) omitted (31.12.2020 immediately before IP completion day) by virtue of The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(36)

[^key-5ea2bb7dff9ed177f3e5e99a437fef89]: Reg. 6(32) omitted (31.12.2020 immediately before IP completion day) by virtue of The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(36)

[^key-968bb86b8b7346eedd64770dded1b688]: Words in reg. 6(33) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(37)(a)

[^key-09c9bef9421451930cd442598596075e]: Words in reg. 6(33) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(37)(b)

[^key-a41af9f692911819f44fca9b0ec3abbb]: Words in reg. 6(33) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(37)(c)

[^key-0e2eeaa6334cac55ddc5949975a64d62]: Words in reg. 6(34) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(38)(a)

[^key-672c668ed940ceb4af6c493fab650e0e]: Word in reg. 6(1) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(2)

[^key-29582169639e6b2f94cac81bb904ea9c]: Words in reg. 6(34) substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(38)(b)(i)

[^key-686efa7c714dc17ea1e18fd7769b8582]: Word in reg. 6(34) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(38)(b)(ii)

[^key-6017891cf342881ff043c95791f067c7]: Word in reg. 6(34) omitted (31.12.2020 immediately before IP completion day) by virtue of The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(38)(b)(iii)

[^key-cfeee189256ef7ef1415c3e04ba3a4a3]: Words in reg. 6(34) omitted (31.12.2020 immediately before IP completion day) by virtue of The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 3(38)(b)(iv)

[^key-2a0c20d2e4cc799b87205918f7471434]: Reg. 7(1A) inserted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 4(b)

[^key-002ae3caa46f2c7b46b4a294e0dc406a]: Words in reg. 7(1) omitted (31.12.2020 immediately before IP completion day) by virtue of The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 4(a)

[^key-06183b0755e7748c5d6a53083e3725dd]: Reg. 9 substituted (31.12.2020 immediately before IP completion day) by The Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1316), regs. 1(3), 5

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.